New Drug Applications Archive - July 2005
Get news by email or subscribe to our news feeds.
July 11, 2005
- Preos New Drug Application Accepted for Review by FDA
- Bayer and Onyx Complete Filing of New Drug Application for Sorafenib for Individuals with Advanced Renal Cell Carcinoma
July 14, 2005
July 15, 2005
July 18, 2005
July 20, 2005
July 22, 2005
July 26, 2005
- Neurocrine Announces Acceptance of New Drug Application for Indiplon Tablets
- Shire and Noven Resubmitted NDA for MTS, a Candidate Treatment for Pediatric ADHD Patients
- Santarus Announces FDA Acceptance of New Drug Application For Zegerid Chewable Tablets
- InKine Announces the Acceptance for Filing of Its New Drug Application (NDA) for Its Next Generation Purgative Product -- INKP-102
July 27, 2005
- Wyeth's New Drug Application for New Oral Contraceptive With Uninterrupted Dosing Regimen Accepted for Filing at FDA
- CV Therapeutics Submits Amendment to Ranexa (ranolazine)
- Wyeth’s NDA for New Oral Contraceptive Accepted for Filing at FDA
